Announcements Trials
Browse Landscape

Status

Recruiting 7Completed 6

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 34Observational 6

Sponsor

Cancer Type

Breast 2Sarcoma 1Genitourinary 1Gastrointestinal 1Classical hematology 1

Conditions

Breast Neoplasms 1388Neoplasms 1167Colorectal Neoplasms 626Lung Neoplasms 562Prostatic Neoplasms 538Carcinoma, Non-Small-Cell Lung 444Carcinoma, Hepatocellular 296Stomach Neoplasms 272Pancreatic Neoplasms 270Colonic Neoplasms 264Ovarian Neoplasms 231Head and Neck Neoplasms 228Rectal Neoplasms 221Melanoma 216Multiple Myeloma 204Uterine Cervical Neoplasms 198Lymphoma 195Leukemia 193Precursor Cell Lymphoblastic Leukemia-Lymphoma 191Neoplasm Metastasis 178Carcinoma, Renal Cell 177Brain Neoplasms 174Esophageal Neoplasms 173Leukemia, Myeloid, Acute 158Urinary Bladder Neoplasms 138Recurrence 123Polycystic Ovary Syndrome 122Liver Neoplasms 119Hematologic Neoplasms 117Endometrial Neoplasms 107

Interventions

Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Observational × Hereditary Sensory and Autonomic Neuropathies × Clear all
NCT04480814 2025-12-30

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC

Pharmassist Ltd

Completed
30 enrolled
Breast

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT05982886 2023-08-09

Biomarker Testing and Treatment Patterns Among Patients With PIK3CA Mutation in Advanced Breast Cancer

Novartis

Completed
1,093 enrolled
Breast

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT04285723 2023-02-09

EPIK-P1

Novartis

Completed
57 enrolled 23 charts 1 FDA

Hereditary Sensory and Autonomic Neuropathies

NCT04425200 2021-12-07

ZENSHIN

AstraZeneca

Completed
205 enrolled
Classical hematologyGenitourinary

Fanconi Anemia, Complementation Group D1, Hereditary Sensory and Autonomic Neuropathies, Prostatic Neoplasms

NCT02171286 2017-04-14

The Oncopanel Pilot (TOP) Study

British Columbia Cancer Agency

Completed
432 enrolled
GastrointestinalSarcoma

Hereditary Sensory and Autonomic Neuropathies, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT02032147 2014-01-09

Treatment of Cerebral Radiation Necrosis (CRN) With Nerve Growth Factor (NGF)

Fudan University

Completed
30 enrolled

Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡